Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib
Open Access
- 1 November 2013
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 54 (11) , 3116-3129
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Lung Cancer Chemoprevention with Celecoxib in Former SmokersCancer Prevention Research, 2011
- Arachidonoyl ethanolamide (AEA)‐induced apoptosis is mediated by J‐series prostaglandins and is enhanced by fatty acid amide hydrolase (FAAH) blockadeMolecular Carcinogenesis, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Celecoxib antagonizes perifosine's anticancer activity involving a cyclooxygenase-2-dependent mechanismMolecular Cancer Therapeutics, 2009
- 15‐deoxy‐delta 12,14‐prostaglandin J2 inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX‐2 in resolution of inflammationJournal of Cellular Physiology, 2008
- Celecoxib for the Prevention of Sporadic Colorectal AdenomasNew England Journal of Medicine, 2006
- Overexpression of Cox-2 in Human Osteosarcoma Cells Decreases Proliferation and Increases ApoptosisCancer Research, 2006
- The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARγ. Influence of albuminJournal of Hepatology, 2005
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Peroxisome Proliferators Enhance Cyclooxygenase-2 Expression in Epithelial CellsJournal of Biological Chemistry, 1999